100 results on '"Ekdahl, Kristina N."'
Search Results
2. 92 Treatment with warfarin but not Factor Xa inhibitors, is associated with dysregulated, noncanonical, complement activation
3. 143 A targeted binding and activation of native C3 without proteolytic cleavage induced by contact with biosurfaces
4. 95 Complement-associated prothrombotic state is caused by MAC-induced lysis of cells
5. Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis
6. Surface modulation of extracellular vesicles with cell-penetrating peptide-conjugated lipids for improvement of intracellular delivery to endothelial cells
7. How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system
8. Regulation of the innate immune system by fragmented heparin-conjugated lipids on lipid bilayered membranes in vitro
9. Impact of spontaneous liposome modification with phospholipid polymer-lipid conjugates on protein interactions
10. Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop
11. Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation
12. Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients
13. A Robust Method to Store Complement C3 With Superior Ability to Maintain the Native Structure and Function of the Protein
14. How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment
15. Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde
16. Effect of liposome surface modification with water-soluble phospholipid polymer chain-conjugated lipids on interaction with human plasma proteins
17. Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective
18. Cell Surface Engineering for Regulation of Immune Reactions in Cell Therapy
19. Thromboinflammation in Therapeutic Medicine
20. Induction of Spontaneous Liposome Adsorption by Exogenous Surface Modification with Cell-Penetrating Peptide-Conjugated Lipids
21. Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis
22. Hemocompatibility of Nanotitania-Nanocellulose Hybrid Materials
23. Pluronic Micelle-Mediated Tissue Factor Silencing Enhances Hemocompatibility, Stemness, Differentiation Potential, and Paracrine Signaling of Mesenchymal Stem Cells
24. Evaluation of the Blood Compatibility of Materials, Cells, and Tissues: Basic Concepts, Test Models, and Practical Guidelines
25. Platelets, Complement, and Contact Activation: Partners in Inflammation and Thrombosis
26. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
27. Cell Surface Functionalization with Heparin‐Conjugated Lipid to Suppress Blood Activation
28. Synthesis of poly(2-methacryloyloxyethyl phosphorylcholine)-conjugated lipids and their characterization and surface properties of modified liposomes for protein interactions
29. Promotion of cell membrane fusion by cell-cell attachment through cell surface modification with functional peptide-PEG-lipids
30. Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q
31. Identification of Metal-Binding Peptides and Their Conjugation onto Nanoparticles of Superparamagnetic Iron Oxides and Liposomes
32. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
33. Assessment of the Role of C3(H2O) in the Alternative Pathway
34. Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis
35. Discrepancies in plasma levels of complement components measured by a newly introduced commercially available magnetic bead technique compared to presently available clinical reference intervals
36. Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
37. Is generation of C3(H2O) necessary for activation of the alternative pathway in real life?
38. Exposure of von Willebrand Factor on Isolated Hepatocytes Promotes Tethering of Platelets to the Cell Surface
39. The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System
40. A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
41. C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases
42. Modification of human MSC surface with oligopeptide‐PEG‐lipids for selective binding to activated endothelium
43. Validation of an MPC Polymer Coating to Attenuate Surface‐Induced Crosstalk between the Complement and Coagulation Systems in Whole Blood in In Vitro and In Vivo Models
44. Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
45. The multifaceted role of complement in kidney transplantation
46. Interpretation of Serological Complement Biomarkers in Disease
47. Development and evaluation of cationic amphiphilic antimicrobial 2,5‐diketopiperazines
48. Contact (kallikrein/kinin) system activation in whole human blood induced by low concentrations of α-Fe2O3 nanoparticles
49. A model to study complement involvement in experimental retinal degeneration
50. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.